DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00451815 (ClinicalTrials.gov)	January 2003	31/1/2006	BIIB014 Phase 2a Monotherapy	A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Multiple Oral Dose Administration of BIIB014 in Subjects With Early Parkinson’s Disease	Parkinson's Disease	Drug: active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.;Drug: placebo	Biogen Idec	NULL	Withdrawn	30 Years	78 Years	Both		Phase 2	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00451815
(ClinicalTrials.gov)

January 2003

31/1/2006

BIIB014 Phase 2a Monotherapy

A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Multiple Oral Dose Administration of BIIB014 in Subjects With Early Parkinson’s Disease

Parkinson's Disease

Drug: active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.;Drug: placebo

Biogen Idec

NULL

Withdrawn

30 Years

78 Years

Both

Phase 2

NULL